New York - Adjuvant therapy with a macrophage-activating growth factor appears to prolong survival in high-risk melanoma, Lynn E. Spitler, M.D., said.
Incyte to Present Numerous Studies at EADV 2023
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
DEF and SDPA Partner to Emphasize Cardiovascular Health for World Heart Day
Discovering Dermatology Times: September 2023
2 Clarke Drive Cranbury, NJ 08512